Clinical Trial

Cerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor

Study acronym: tACS_PD_TR
Recruiting
View on ClinicalTrials.gov →
Summary
Parkinson's disease (PD) is a prevalent neurodegenerative disorder characterized by different motor symptoms, including tremor, which is particularly difficult to manage. Common treatments, such as dopaminergic therapy, can have limitations in efficacy. Recent advancements in non-invasive brain stimulation, specifically phase-adaptive transcranial alternating current stimulation (tACS), offer a promising approach to reduce PD tremor. In the current project, a newly developed closed-loop system delivers precisely synchronized cerebellar tACS by aligning stimulation with the intrinsic hand tremor signal. The study will assess the efficacy of this novel approach to reduce hand tremor in PD patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-19.
Trial Details
NCT Number NCT06993571
Lead Sponsor Universitätsklinikum Hamburg-Eppendorf
Conditions Parkinson's Disease (PD), Tremor
Enrollment 10 participants
Start Date 2025-04-16
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-04